Role of PACAP in female fertility and reproduction at gonadal level - recent advances

Frontiers in Endocrinology

Volumn 3, Issue DEC, 2012, Pages

  Reglodi, Dora ^a   Tamas, Andrea ^a   Koppan, Miklos ^b   Szogyi, Donat ^b   Welke, Laura ^c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c ROSS UNIVERSITY SCHOOL OF MEDICINE   (Dominica)

Author keywords

Luteinization; Oocyte; Ovary; Ovulation; Pacap

Indexed keywords

EID: 84874440016     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00155     Document Type: Review

References (81)

1. Apa, R., Lanzone, A., Mastrandrea, M., Miceli, F., de Feo, D., Caruso, A., et al. (1997). Control of human luteal steroidogenesis: role of growth hormone-releasing hormone, vasoactive intestinal peptide, and pituitary adenylate cyclaseactivating peptide. Fertil. Steril. 68, 1097-1102.
2. Apa, R., Lanzone, A., Miceli, F., Vaccari, S., Macchione, E., Stefanini, M., et al. (2002). Pituitary adenylate cyclaseactivating polypeptide modulates plasminogen activator expression in rat granulosa cell. Biol. Reprod. 66, 830-835.
3. Apostolakis, E. M., Lanz, R., and O'Malley, B. W. (2004). Pituitary adenylate cyclase-activating peptide: a pivotal modulator of steroidinduced reproductive behavior in female rodents. Mol. Endocrinol. 18, 173-183.
4. Apostolakis, E. M., Riherd, D. N., and O'Malley, B. W. (2005). PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptideand progesteronefacilitated receptivity in female rats. Mol. Endocrinol. 19, 2798-2811.
5. Arimura, A. (2007). PACAP: the road to discovery. Peptides 28, 1617-1619.
6. Arimura, A., Somogyvari-Vigh, A., Miyata, A., Mizuno, K., Coy, D. H., and Kitada, C. (1991). Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 129, 2787-2789.
7. Aubert, N., Vaudry, D., Falluel-Morel, A., Desfeux, A., Fisch, C., Ancian, P., et al. (2008). PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: involvement of the mitochondrial apoptotic pathway. Neurobiol. Dis. 32, 66-80.
8. Barberi, M., Muciaccia, B., Morelli, M. B., Stefanini, M., Cecconi, S., and Canipari, R. (2007). Expression localisation and functional activity of pituitary adenylate cyclaseactivating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. Reproduction 134, 281-292.
9. Bodis, J., Koppan, M., Kornya, L., Tinneberg, H. R., and Torok, A. (2001). Influence of melatonin on basal and gonadotropin-stimulated progesterone and estradiol secretion of cultured human granulosa cells and in the superfused granulosa cell system. Gynecol. Obstet. Invest. 52, 198-202.
10. Boronkai, A., Brubel, R., Racz, B., Tamas, A., Kiss, P., Horvath, G., et al. (2009). Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the survival and signal transduction pathways in human choriocarcinoma cells. Ann. N. Y. Acad. Sci. 1163, 353-357.
11. Borzsei, R., Mark, L., Tamas, A., Bagoly, T., Bay, C., Csanaky, K., et al. (2009). Presence of pituitary adenylate cyclase activating polypeptide38 in human plasma and milk. Eur. J. Endocrinol. 160, 561-565.
12. Brubel, R., Boronkai, A., Reglodi, D., Racz, B., Nemeth, J., Kiss, P., et al. (2010). Changes in the expression of pituitary adenylate cyclaseactivating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cells. J. Mol. Neurosci. 42, 450-458.
13. Brubel, R., Reglodi, D., Jambor, E., Koppan, M., Varnagy, A., Biro, Z., et al. (2011). Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry. J. Mass Spectrom. 46, 189-194.
14. Cecconi, S., Rossi, G., Barberi, M., Scaldaferri, L., and Canipari, R. (2004). Effect of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on mouse preantral follicle development in vitro. Endocrinology 145, 2071-2079.
15. Counis, R., Laverriere, J. N., GarrelLazayres, G., Cohen-Tannoudji, J., Lariviere, S., Bleux, C., et al. (2007). What is the role of PACAP in gonadotrope function? Peptides 28, 1797-1804.
16. Csanaky, K., Banki, E., Szabadfi, K., Reglodi, D., Tarcai, I., Czegledi, L., et al. (2012). Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation. J. Mol. Neurosci. 48, 631-637.
17. Delgado, M., and Ganea, D. (2000). Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression. J. Immunol. 164, 1200-1210.
18. Fabian, E., Reglodi, D., Mester, L., Szabo, A., Szabadfi, K., Tamas, A., et al. (2012). Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress. J. Mol. Neurosci. 48, 493-500.
19. Fahrenkrug, J., and Hannibal, J. (1996). Pituitary adenylate cyclase activating polypeptide innervation of the rat female reproductive tract and the associated paracervical ganglia: effect of capsaicin. Neuroscience 73, 1049-1060.
20. Fahrenkrug, J., Steenstrup, B. R., Hannibal, J., Alm, P., and Ottesen, B. (1996). Role of PACAP in the female reproductive organs. Ann. N. Y. Acad. Sci. 805, 394-407.
21. Flaws, J.A., DeSanti, A., Tilly, K. I., Kugu, K., Johnson, A. L., Hirschfield, A. N., et al. (1995). Vasoactive intestinal peptide-mediated suppression of apoptosis in the ovary: potential mechanisms of action and evidence of a conserved antiatretogenic role through evolution. Endocrinology 136, 4351-4359.
22. Gottschall, P. E., Tatsuno, I., Miyata, A., and Arimura, A. (1990). Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclaseactivating polypeptide. Endocrinology 127, 272-277.
23. Gras, S., Hannibal, J., Georg, B., and Fahrenkrug, J. (1996). Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells. Endocrinology 137, 4779-4785.
24. Gras, S., Hedetoft, C., Pedersen, S. H., and Fahrenkrug, J. (2000). Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/lutein cells via two receptor subtypes. Biol. Reprod. 63, 206-212.
25. Gras, S., Host, E., and Fahrenkrug, J. (2005). Role of pituitary adenylate cyclase-activating peptide (PACAP) in the cyclic recruitment of immature follicles in the rat ovary. Regul. Pept. 128, 69-74.
26. Gutierrez-Canas, I., Rodriguez-Henche, N., Bolanos, O., Carmena, M. J., Prieto, J. C., and Juarranz, M. G. (2003). VIP and PACAP are autocrine factors that protect the androgenindependent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal. Br. J. Pharmacol. 139, 1050-1058.
27. Heindel, J. J., Sneeden, J., Powell, A. J., Davis, B., and Culler, M. D. (1996). A novel hypothalamic peptide, pituitary adenylate cyclase activating peptide, regulates the function of rat granulose cells in vitro. Biol. Reprod. 54, 523-530.
28. Hong, X., Huang, L., and Song, Y. (2008). Role of vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide in the vaginal wall of women with stress urinary incontinence and pelvic organ prolapse. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 1151-1157.
29. Isaac, E. R., and Sherwood, N. M. (2008). Pituitary adenylate cyclaseactivating polypeptide (PACAP) is important for embryo implantation in mice. Mol. Cell. Endocrinol. 280, 13-19.
30. Kato, M., Hanaoka, Y., Tatemoto, K., and Kimura, C. (1997). Hyperpolarization-activated Clcurrent elicited by pituitary adenylate cyclase activating polypeptide in Xenopus oocytes. Regul. Pept. 70, 167-172.
31. Ko, C., In, Y. H., and Park-Sarge, O. K. (1999). Role of progesterone receptor activation in pituitary adenylate cyclase activating polypeptide gene expression in rat ovary. Endocrinology 140, 5185-5194.
32. Ko, C., and Park-Sarge, O. K. (2000). Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC1) gene expression in rat granulose cells. Biochem. Biophys. Res. Commun. 277, 270-279.
33. Koh, P. O., Won, C. K., Noh, H. S., Cho, G. J., and Choi, W. S. (2005). Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta. J. Vet. Sci. 6, 1-5.
34. Koppan, M., Varnagy, A., Reglodi, D., Brubel, R., Nemeth, J., Tamas, A., et al. (2012). Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase-activating polypeptide (PACAP) in women after superovulation treatment. J. Mol. Neurosci. 48, 617-622.
35. Kotani, E., Usuki, S., and Kubo, T. (1997). Rat corpus luteum expresses both PACAP and PACAP type IA receptor mRNAs. Peptides 18, 1453-1455.
36. Kotani, E., Usuki, S., and Kubo, T. (1998). Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on progestin biosynthesis in cultured granulosa cells from rat ovary and expression of mRNA encoding PACAP type I receptor. J. Reprod. Fertil. 112, 107-114.
37. Koves, K., Kantor, O., Molnar, J., Heinzlmann, A., Szabo, E., Szabo, F., et al. (2003). The role of PACAP in gonadotropic hormone secretion at hypothalamic and pituitary levels. J. Mol. Neurosci. 20, 141-152.
38. Koves, K., Molnar, J., Kantor, O., Lakatos, A., Fogel, K., Kausz, M., et al. (1998). Role of PACAP in the regulation of gonadotroph hormone secretion during ontogenesis: a single neonatal injection of PACAP delays puberty and its intracerebroventricular administration before the critical period of proestrous stage blocks ovulation in adulthood. Ann. N. Y. Acad. Sci. 865, 590-594.
39. Koves, K., Molnar, J., Kantor, O., Lakatos, A., Gorcs, T. J., Somogyvari-Vigh, A., et al. (1996). PACAP participates in the regulation of the hormonal events preceeding the ovulation. Acta Biol. Hung. 47, 239-249.
40. Latini, S., Chiarpotto, M., Muciaccia, B., Vaccari, S., Barberi, M., Guglielmo, M. C., et al. (2010). Inhibitory effect of pituitary adenylate cyclase activating polypeptide on the initial stages of rat follicle development. Mol. Cell. Endocrinol. 320, 34-44.
41. Lee, J., Park, H. J., Choi, H. S., Kwon, H. B., Arimura, A., Lee, B. J., et al. (1999). Gonadotropin stimulation of pituitary adenylate cyclase activating polypeptide (PACAP) messenger ribonucleic acid in the rat ovary and the role of PACAP as a follicle survival factor. Endocrinology 140, 818-826.
42. Levy, G., David, D., and Degani, G. (2011). Effect of environmental temperature on growthand reproduction-related hormones gene expression in the female blue gourame (Trichogaster trichopterus). Comp. Biochem. Physiol. Part A Mol. Integr. Physiol. 160, 381-189.
43. Levy, G., and Degani, G. (2011). Evidence of a reproduction-related function for pituitary adenylate cyclase activating polypeptiderelated peptide in an Anabantidae fish. J. Mol. Endocrinol. 46, 101-110.
44. Levy, G., and Degani, G. (2012). Involvement of GnRH, PACAP and PRP in the reproduction of blue gourami females (Trichogaster trichopterus). J. Mol. Neurosci. 48, 603-616.
45. Levy, G., Jackson, K., and Degani, G. (2010). Association between pituitary adenylate cyclase activating polypeptide and reproduction in the blue gourami. Gen. Comp. Endocrinol. 166, 83-93.
46. Li, M., Mbikay, M., and Arimura, A. (2000). Pituitary adenylate cyclase-activating polypeptide precursor is processed solely by prohormone convertase 4 in the gonads. Endocrinology 141, 3723-3730.
47. Matsuda, F., Inoue, N., Manabe, N., and Ohkura, S. (2012). Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells. J. Reprod. Dev. 58, 44-50.
48. Mayerhofer, A., Dissen, G. A., Costa, M. E., and Ojeda, S. R. (1997). A role for neurotransmitters in early follicular development: induction of functional follicle-stimulating hormone receptors in newly formed follicles of the rat ovary. Endocrinology 138, 3320-3329.
49. Miyata, A., Arimura, A., Dahl, R. R., Minamino, N., Uehara, A., Jiang, L., et al. (1989). Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164, 567-574.
50. Morelli, M. B., Barberi, M., Gambardella, A., Borini, A., Cecconi, S., Coticchio, G., et al. (2008). Characterization, expression, and functional activity of pituitary adenylate cyclase-activating polypeptide and its receptors in human granulosaluteal cells. J. Clin. Endocrinol. Metab. 93, 4924-3492.
51. Nussdorfer, G. G., and Malendowicz, L. K. (1998). Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19, 1443-1467.
52. Odum, L., and Fahrenkrug, J. (1998). Pituitary adenylate cyclase activating polypeptide (PACAP) in human ovarian cancers. Cancer Lett. 125, 185-189.
53. Park, H. J., Lee, J., Wang, L., Park, J. H., Kwon, H. B., and Arimura, A. (2000). Stage-specific expression of pituitary adenylate cyclase activating polypeptide type I receptor messenger ribonucleic acid during ovarian follicle development in the rat. Endocrinology 141, 702-709.
54. Park, J. Y., Park, J. H., Park, H. J., Lee, J. Y., Lee, Y. I., Lee, K., et al. (2001). Stage-dependent regulation of ovarian pituitary adenylate cyclase-activating polypeptide mRNA levels by GnRH in cultured rat granulosa cells. Endocrinology 142, 3828-3835.
55. Pesce, M., Canipari, R., Ferri, G. L., Siracusa, G., and De Felici, M. (1996). Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates adenylate cyclase and promotes proliferation of mouse primordial germ cells. Development 122, 215-221.
56. Pirger, Z., Nemeth, J., Hiripi, L., Toth, G., Kiss, P., Lubics, A., et al. (2008). PACAP has antiapoptotic effect in the salivary gland of an invertebrate species, Helix pomatia. J. Mol. Neurosci. 36, 105-114.
57. Racz, B., Gasz, B., Borsiczky, B., Gallyas, F., Jr. Tamas, A., Jozsa, R., et al. (2007). Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis. Gen. Comp. Endocrinol. 153, 115-123.
58. Rawlings, S. R., and Hezareh, M. (1996). Pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP/Vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocr. Rev. 17, 4-29.
59. Reglodi, D., Gyarmati, J., Ertl, T., Borzsei, R., Bodis, J., Tamas, A., et al. (2010). Alterations of pituitary adenylate cyclase activating polypeptide (PACAP)-like immunoreactivity in the human plasma during pregnancy and after birth. J. Endocrinol. Invest. 33, 443-445.
60. Reglodi, D., Kiss, P., Szabadfi, K., Atlasz, T., Gabriel, R., Horvath, G., et al. (2012). PACAP is an endogenous protective factor - insights from PACAP deficient mice. J. Mol. Neurosci. 48, 482-492.
61. Sadler, T. W. (2012). Medical Embriology. Baltimore: Lippincott Williams and Wilkins.
62. Sayasith, K., Brown, K. A., and Sirois, J. (2007). Gonadotropin-dependent regulation of bovine pituitary adenylate cyclase-activating polypeptide in ovarian follicles prior to ovulation. Reproduction 133, 441-453.
63. Scaldaferri, L., Arora, K., Lee, S. H., Catt, K. J., and Moretti, C. (1996). Expression of PACAP and its type-I receptor isoforms in the rat ovary. Mol. Cell. Endocrinol. 117, 227-232.
64. Scaldaferri, M. L., Modesti, A., Palumbo, C., Ulisse, S., Fabbri, A., Piccione, E., et al. (2000). Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAPreceptor type 1 expression in rat and human placenta. Endocrinology 141, 1158-1167.
65. Sherwood, N. M., Adams, B. A., Isaac, E. R., Wu, S., and Fradinger, E. A. (2007). Knocked down and out: PACAP in development, reproduction and feeding. Peptides 28, 1680-1687.
66. Sherwood, N. M., Krueckl, S. L., and McRory, J. E. (2000). The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 21, 619-670.
67. Shintani, N., Mori, W., Hashimoto, H., Imai, M., Tanaka, K., Tomimoto, S., et al. (2002). Defects in reproductive functions in PACAP-deficient female mice. Regul. Pept. 109, 45-48.
68. Somogyvari-Vigh, A., and Reglodi, D. (2004). Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr. Pharm. Des. 10, 2861-2889.
69. Steenstrup, B. R., Alm, P., Hannibal, J., Jorgensen, J. C., Palle, C., Junge, J., et al. (1995). Pituitary adenylate cyclase activating polypeptide: occurrence and relaxant effect in female genital tract. Am. J. Physiol. 269, E108-E117.
70. Steenstrup, B. R., Jorgensen, J. C., Alm, P., Hannibal, J., Junge, J., Fahrenkrug, J., et al. (1996). Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilatory effect in the human uteroplacental unit. Regul. Pept. 61, 197-204.
71. Szabo, F., Horvath, J., Heinzlmann, A., Arimura, A., and Koves, K. (2002). Neonatal PACAPadministration in rats delays puberty through the influence of the LHRH neuronal system. Regul. Pept. 109, 49-55.
72. Usuki, S., and Kotani, E. (2001). Effect of pituitary adenylate cyclaseactivating polypeptide (PACAP) on progestin biosynthesis in cultured luteal cells from rat ovary. Gynecol. Endocrinol. 15, 184-191.
73. Usuki, S., and Kotani, E. (2002). Tokishakuyakusan directly attenuates PACAP's luteolytic action on luteal function in therat ovary.Am. J. Chin. Med. 30, 521-531.
74. Vaccari, S., Latini, S., Barberi, M., Teti, A., Stefanini, M., and Canipari, R. (2006). Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles. J. Endocrinol. 191, 287-299.
75. Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., et al. (2009). Pituitary adenylate cyclase activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 61, 283-357.
76. Vaudry, D., Ravni, A., Wurtz, O., Benard, M., Botia, B., and Jolivel, V. (2006). "Effects of PACAP in the local regulationof endocrineglands, "inHandbook of Biologically Active Peptides, ed. A. J. Kastin (London: Academic Press), 867-874.
77. Vaudry, D., Rousselle, C., Basille, M., Falluel-Morel, A., Pamantung, T. F., Fontaine, M., et al. (2002). Pituitary adenylate cyclase activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 99, 6398-6403.
78. Wang, Y., Wong, A. O., and Ge, W. (2003). Cloning, regulation of messenger ribonucleic acid expression, and function of a new isoform of pituitary adenylate cyclase activating polypeptide in the zebrafish ovary. Endocrinology 144, 4799-4810.
79. Zhao, W., Cheng, D. L., Zheng, H. L., Zhu, H., and Ni, J. (2010). Expression and regulation of pituitary adenylate cyclase activating polypeptide mRNA in pregnant rat corpus luteum. Zhongguo Ying Yong Sheng Li Xue Za Zhi 26, 313-317.
80. Zhong, Y., and Kasson, B. G. (1994). Pituitary adenylate cyclaseactivating polypeptide stimulates steroidogenesis and adenosine 3', 5'-monophosphate accumulation in cultured rat granulosa cells. Endocrinology 135, 207-213.
81. Ziessen, T., Moncada, S., and Cellek, S. (2002). Characterization of the non-nitrergic NANC relaxation responses in the rabbit vaginal wall. Br. J. Pharmacol. 135, 546-554.